WBA Share Price Performance
US$11.98
3.74 (45.39%)
0.4% overvalued intrinsic discount
US$11.93
Fair Value
Price US$11.98
AnalystConsensusTarget US$11.93
AnalystLowTarget US$10.00
AnalystHighTarget US$14.10
Fair ValueUS$11.93
Share Pricen/a
Walgreens Boots Alliance, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 185 Fair Values set on narratives written by author
WBA Community Narratives
AN
Fair Value US$11.93 0.4% overvalued intrinsic discount
Operational Optimizations Will Drive Future Profitability In Retail And Pharmacy
2users have liked this narrative
0users have commented on this narrative
91users have followed this narrative
AN
Fair Value US$10 19.8% overvalued intrinsic discount
Digital Shift Will Erode Retail And Pharmacy Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$14.1 15.0% undervalued intrinsic discount
Digital Health And An Aging Population Will Expand Retail Care
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Operational Optimizations Will Drive Future Profitability In Retail And Pharmacy
Key Takeaways Store optimization and labor management improvements are expected to enhance net margins by reducing costs and increase customer satisfaction. Increasing pharmacy efficiency and expanding product lines aim to boost revenues and safeguard against reimbursement pressures, enhancing gross margins.Read more
2users have liked this narrative
0users have commented on this narrative
91users have followed this narrative
AN
US$11.93
0.4% overvalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
0.84% p.a.
Profit Margin
0.25%
Future PE
36.28x
Share price in 2028
US$16.55
Digital Health And An Aging Population Will Expand Retail Care
Key Takeaways Store optimization, automation, and digital health investments are driving stronger margins, higher operating leverage, and long-term earnings growth through increased prescription volumes and cost efficiencies. Expansion into health services, own brands, and integrated care uniquely positions the company to boost customer loyalty, revenue diversity, and structural margin improvement.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$14.1
15.0% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
4.35% p.a.
Profit Margin
0.68%
Future PE
14.25x
Share price in 2028
US$19.57
Digital Shift Will Erode Retail And Pharmacy Margins
Key Takeaways Rapid consumer shift to digital healthcare and e-commerce is eroding the relevance and profitability of Walgreens' brick-and-mortar retail model. Persistent underinvestment in technology and mounting regulatory pressures are constraining margins, competitiveness, and long-term sales growth.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$10
19.8% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
-0.024% p.a.
Profit Margin
2.72%
Future PE
2.93x
Share price in 2028
US$13.9
Recently Updated Narratives
AN
Digital Shift Will Erode Retail And Pharmacy Margins
Fair Value: US$10 19.8% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Digital Health And An Aging Population Will Expand Retail Care
Fair Value: US$14.1 15.0% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Operational Optimizations Will Drive Future Profitability In Retail And Pharmacy
Fair Value: US$11.93 0.4% overvalued intrinsic discount
91 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Walgreens Boots Alliance, Inc. Key Details
Last Reported Earnings
May 31, 2025
Next Reporting Earnings
n/a
- -7.28
- 17.13%
- -4.07%
- 100.7%
About WBA
- Founded
- 1909
- Employees
- 252500
- CEO
- WebsiteView website
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients’ homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
